We are live on ! Find out more
ASBPW

Aspire Biopharma Warrant
ASBPW

29 hedge funds and large institutions have $151K invested in Aspire Biopharma Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$342
2
+$10

Top Sellers

1
-$6.96K
2
-$4.93K
3
-$2
4
CS
Clear Street
New York
-$2
Name Holding Trade Value Shares
Change 		Change in
Stake
BPA
26
Beacon Pointe Advisors
California
$332
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$279
Barclays
28
Barclays
United Kingdom
$145
FTUS
29
Flow Traders U.S.
New York
–
1
2